CHANGMAO BIO issues a profit warning, expecting a mid-term net loss of approximately 24 million to 27 million yuan
I'm PortAI, I can summarize articles.
CHANGMAO BIO issued a profit warning, expecting a consolidated net loss attributable to the company's shareholders of approximately RMB 24 million to 27 million for the six months ending June 30, 2025, an increase from the loss of RMB 18.786 million for the six months ending June 30, 2024. The board pointed out that the financial performance was affected by factors such as declining product sales prices, intensified market competition, and increased interest expenses
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments